BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 55309)

  • 41. Soluble factors from peripheral blood T-cells of patients with polycythemia vera stimulate normal BFU-E.
    Cassel A; Braester A; Quitt M; Froom P; Aghai E
    Leukemia; 1993 Sep; 7(9):1370-3. PubMed ID: 8371588
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Binding of human lymphotoxin to target-cell membranes and its relation to cell-mediated cytodestruction.
    Hessinger DA; Daynes RA; Granger GA
    Proc Natl Acad Sci U S A; 1973 Nov; 70(11):3082-6. PubMed ID: 4544711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Study of the cellular origin of histamine release inhibitory factor using highly purified subsets of mononuclear cells.
    Alam R; Forsythe PA; Lett-Brown MA; Grant JA
    J Immunol; 1989 Oct; 143(7):2280-4. PubMed ID: 2476505
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanisms of delayed hypersensitivity.
    McCluskey RT; Cohen S
    Pathobiol Annu; 1972; 2():111-28. PubMed ID: 4589745
    [No Abstract]   [Full Text] [Related]  

  • 45. Genetic control of phytohemagglutinin responsiveness by murine spleen cells and correlation between the release of lymphotoxins and DNA synthesis.
    Donner M; Vaillier D; Burg C
    Eur J Immunol; 1973 Jul; 3(7):424-9. PubMed ID: 4128133
    [No Abstract]   [Full Text] [Related]  

  • 46. Induction of macrophage procoagulant by products of activated lymphocytes.
    Geczy CL
    Haemostasis; 1984; 14(5):400-11. PubMed ID: 6398241
    [TBL] [Abstract][Full Text] [Related]  

  • 47. On the molecular basis of T-helper-cell function. IV. B-lymphocyte-promotor factors: on their mode of action, biochemical nature and possible relationship to molecules involved in specific T-helper-cell activity.
    Reininger L; Fueri J; Boned A; Prat M; Landolfo S; Rubin B
    Cell Immunol; 1985 Apr; 92(1):85-104. PubMed ID: 2416480
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytotoxic lymphokines produced by cloned human cytotoxic T lymphocytes. II. A novel CTL-produced cytotoxin that is antigenically distinct from tumor necrosis factor and alpha-lymphotoxin.
    Green LM; Reade JL; Ware CF; Devlin PE; Liang CM; Devlin JJ
    J Immunol; 1986 Dec; 137(11):3488-93. PubMed ID: 2431035
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A role for cell-mediated immunity in the pathogenesis of periodontal disease.
    Horton JE; Oppenheim JJ; Mergenhagen SE
    J Periodontol; 1974 May; 45(5):351-60. PubMed ID: 4600302
    [No Abstract]   [Full Text] [Related]  

  • 50. Signal requirements for growth and differentiation of activated murine B lymphocytes.
    Müller W; Kühn R; Goldmann W; Tesch H; Smith FI; Radbruch A; Rajewsky K
    J Immunol; 1985 Aug; 135(2):1213-9. PubMed ID: 3874233
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells.
    Ware CF; Crowe PD; Grayson MH; Androlewicz MJ; Browning JL
    J Immunol; 1992 Dec; 149(12):3881-8. PubMed ID: 1281193
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of immunotherapy on the production of IgE regulatory soluble factors. The response of normal lymphocytes.
    Tokushima M; Sanz ML; de las Marinas MD; Fernández JF; Oehling A
    Allergol Immunopathol (Madr); 1990; 18(2):63-8. PubMed ID: 2371942
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FcR epsilon+ lymphocytes and regulation of the IgE antibody system. I. A new class of molecules, termed IgE-induced regulants (EIR), which modulate FcR epsilon expression by lymphocytes.
    Marcelletti JF; Katz DH
    J Immunol; 1984 Dec; 133(6):2821-8. PubMed ID: 6238084
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytotoxic lymphokines produced by cloned human cytotoxic T lymphocytes. I. Cytotoxins produced by antigen-specific and natural killer-like CTL are dissimilar to classical lymphotoxins.
    Green LM; Stern ML; Haviland DL; Mills BJ; Ware CF
    J Immunol; 1985 Dec; 135(6):4034-43. PubMed ID: 2415596
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cellular origin of histamine-releasing factor produced by peripheral blood mononuclear cells.
    Alam R; Forsythe PA; Lett-Brown MA; Grant JA
    J Immunol; 1989 Jun; 142(11):3951-6. PubMed ID: 2469728
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phenotypic characterization of human T lymphocyte populations producing macrophage-activating factor (MAF) lymphokines.
    Biondi A; Roach JA; Schlossman SF; Todd RF
    J Immunol; 1984 Jul; 133(1):281-5. PubMed ID: 6373929
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of lymphotoxin beta governs immunity at two distinct levels.
    Junt T; Tumanov AV; Harris N; Heikenwalder M; Zeller N; Kuprash DV; Aguzzi A; Ludewig B; Nedospasov SA; Zinkernagel RM
    Eur J Immunol; 2006 Aug; 36(8):2061-75. PubMed ID: 16841297
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Participation of soluble H-2 antigens in serological and cellular reactions].
    Pletneva TP; Kaulen DR; Khorobrykh VV; Kirkin AF; Kotomina IF
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1979; (5):24-8. PubMed ID: 88233
    [No Abstract]   [Full Text] [Related]  

  • 59. Ephrin B2 induces T cell costimulation.
    Yu G; Luo H; Wu Y; Wu J
    J Immunol; 2003 Jul; 171(1):106-14. PubMed ID: 12816988
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular pharmacology of cell-mediated immunity.
    Dumonde DC; Kelly RH; Wolstencroft RA
    Adv Exp Med Biol; 1973; 29(0):705-11. PubMed ID: 4546868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.